Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Interra Health is a private healthcare technology company focused on prescription access, ePrescribing, and pharmacy and medical benefit transparency rather than therapeutic drug development. Formed in March 2026 through the merger of DoseSpot and Arrive Health, and described on its website as unifying the capabilities of DoseSpot, Arrive Health, and pVerify, the company provides real-time coverage, affordability, eligibility, authorization, and pharmacy information at the point of care. Its products are designed to help providers make more confident prescribing decisions and help patients understand medication access and fulfillment options. Interra Health serves providers, patients, payers, PBMs, life sciences partners, and health-tech developers through a data and workflow infrastructure embedded in prescribing workflows. The business appears to be a commercial-stage health IT platform, not a biotech or pharma company with a drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Interra Health.